Skip to content
Parakho

Advanced Enzyme Technologies Ltd

NSE ADVENZYMESBSE 540025advancedenzymes.com

Q1 FY27, unaudited

Revenue
₹189.79 Cr
Profit after tax
₹38.59 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations189.79+2.08%745.76
Other income13.02+47.13%34.83
Total income202.81+4.13%780.59
Employee benefit expense44.55+12.18%162.29
Finance costs0.58−24.08%2.63
Depreciation & amortisation9.88+2.71%40.09
Total expenses149.28+6.73%559.41
Profit before tax53.53−2.50%232.54
Tax expense14.94+3.30%58.93
Profit after tax38.59−4.58%173.61
Total comprehensive income37.16−15.94%268.42
Earnings per share
Earnings per share, basic₹3.31₹15.08
Earnings per share, diluted₹3.31₹15.06

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Advanced Enzyme Technologies reported its highest-ever quarterly and annual revenue for FY26, with Q4 revenue of INR 2,034 million, up 22% YoY, and full-year revenue of INR 7,458 million, up 17%. EBITDA margin remained at 31% for both the quarter and the year, while PAT grew 69% YoY in Q4 and 30% for the full year. Management attributed the growth to strength across Human Healthcare, Animal Healthcare, Bioprocessing and Specialized Manufacturing segments, and flagged input cost inflation and U.S. market uncertainty as ongoing considerations for the coming year.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 55 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 25 Aug 2026.